The Merck Global Health Innovation Fund (GHI) went live in late 2010 as a strategic response to the challenges surrounding Merck’s core business. The objective of the fund is to provide insight to Merck on how the digital health space is unfolding, as well as to provide option value to expand into emerging segments of healthcare. GHI makes equity investments in companies that we believe will have disproportionate value in the digital health ecosystem.